[go: up one dir, main page]

YU48594B - N-N'-DIACETYLCYSTINE ORGANIC SALTS AND THE PROCESS FOR THEIR PREPARATION - Google Patents

N-N'-DIACETYLCYSTINE ORGANIC SALTS AND THE PROCESS FOR THEIR PREPARATION

Info

Publication number
YU48594B
YU48594B YU99092A YU99092A YU48594B YU 48594 B YU48594 B YU 48594B YU 99092 A YU99092 A YU 99092A YU 99092 A YU99092 A YU 99092A YU 48594 B YU48594 B YU 48594B
Authority
YU
Yugoslavia
Prior art keywords
diacetylcystine
preparation
organic salts
forms
organic
Prior art date
Application number
YU99092A
Other languages
Serbo-Croatian (sh)
Other versions
YU99092A (en
Inventor
Carl-Magnus Andersson
Hakan Bergstrand
Edib Jakupovic
Bo-Goran Josefsson
Magnus Lindvall
Bengt Sarnstrand
Eric Teneberg
Original Assignee
Aktiebolaget Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Astra filed Critical Aktiebolaget Astra
Publication of YU99092A publication Critical patent/YU99092A/en
Publication of YU48594B publication Critical patent/YU48594B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/22—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of hydropolysulfides or polysulfides
    • C07C319/24—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of hydropolysulfides or polysulfides by reactions involving the formation of sulfur-to-sulfur bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

So organske baze i N,N'-diacetil-cistina u obliku njegovih pojedinačnih izomera, tj. kao D-, L- i mezo-oblici, kao i njegovi racemski oblici (DiNAc), naznačena time, što ima opštu formulu: gde je R+ i R2+ katjon organske baze, izabran iz grupe koju čine lizin, etilendiamin, N,N'-dibenziletilendiamin, adamantanamin, N-benzil-2-feniletilamin ili piperazin. -Prijava sadrži još 1 nezavisan i 2 zavisna zahteva.Salt of organic bases and N, N'-diacetyl-cystine in the form of its individual isomers, ie. as D-, L- and meso-forms, as well as its racemic forms (DiNAc), having the general formula: wherein R + and R2 + are an organic base cation selected from the group consisting of lysine, ethylenediamine, N, N ' -dibenzylethylenediamine, adamantanamine, N-benzyl-2-phenylethylamine or piperazine. -The application contains 1 more independent and 2 dependent requests.

YU99092A 1991-11-29 1992-11-18 N-N'-DIACETYLCYSTINE ORGANIC SALTS AND THE PROCESS FOR THEIR PREPARATION YU48594B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9103572A SE9103572D0 (en) 1991-11-29 1991-11-29 ORGANIC SALTS OF N, N'-DIACETYL CYSTINE

Publications (2)

Publication Number Publication Date
YU99092A YU99092A (en) 1995-12-04
YU48594B true YU48594B (en) 1998-12-23

Family

ID=20384494

Family Applications (1)

Application Number Title Priority Date Filing Date
YU99092A YU48594B (en) 1991-11-29 1992-11-18 N-N'-DIACETYLCYSTINE ORGANIC SALTS AND THE PROCESS FOR THEIR PREPARATION

Country Status (38)

Country Link
US (5) US5385904A (en)
EP (1) EP0621862B1 (en)
JP (1) JP3302018B2 (en)
KR (1) KR100256185B1 (en)
CN (1) CN1039586C (en)
AP (1) AP350A (en)
AT (1) ATE141913T1 (en)
AU (1) AU657827B2 (en)
CA (1) CA2123516A1 (en)
CZ (1) CZ282085B6 (en)
DE (1) DE69213256T2 (en)
DK (1) DK0621862T3 (en)
DZ (1) DZ1637A1 (en)
EE (1) EE03025B1 (en)
ES (1) ES2090713T3 (en)
FI (1) FI942504L (en)
GR (1) GR3021546T3 (en)
HK (1) HK62297A (en)
HR (1) HRP921322B1 (en)
HU (1) HU215390B (en)
IL (1) IL103778A (en)
IS (1) IS1645B (en)
LV (1) LV11949B (en)
MA (1) MA22716A1 (en)
MX (1) MX9206851A (en)
MY (1) MY110523A (en)
NO (1) NO301325B1 (en)
NZ (1) NZ245077A (en)
PL (2) PL170787B1 (en)
RU (1) RU2135468C1 (en)
SE (1) SE9103572D0 (en)
SG (1) SG73962A1 (en)
SI (1) SI9200351A (en)
SK (1) SK281697B6 (en)
TN (1) TNSN92108A1 (en)
WO (1) WO1993011104A1 (en)
YU (1) YU48594B (en)
ZA (1) ZA928739B (en)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865463A (en) * 1973-11-12 1975-02-11 Busch & Co Inc Ag Electrical adapter plug
EP0715853A1 (en) * 1991-01-10 1996-06-12 Transcend Therapeutics, Inc. Use of glutathione esters for the treatment of pulmonary diseases
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
SE9500897D0 (en) * 1995-03-14 1995-03-14 Astra Ab The pharmacological use of certain cysteine derivatives
SE9602262D0 (en) * 1996-06-06 1996-06-06 Astra Ab New use of cystine derivatives
SE9602416D0 (en) * 1996-06-18 1996-06-18 Astra Ab New forms of an organic salt of N'N-diacetylcystine
AR007398A1 (en) * 1996-06-18 1999-10-27 Astrazeneca Ab PROCESS TO PREPARE INORGANIC SALTS OF N-N'-DIACETILCISTINA
US6017959A (en) * 1996-06-18 2000-01-25 Astra Aktiebolag Forms of organic salts of N,N'-diacetylcystine
CN1059907C (en) * 1997-05-23 2000-12-27 中国石油化工集团公司巴陵石化岳阳石油化工总厂 Selective hydrogenation method for conjugated dienes polymer
US6197749B1 (en) * 1997-10-29 2001-03-06 Ajinomoto Co., Inc. Method of suppressing immune responses by reducing intracellular content of glutathione in macrophages and monocytes
US20030203006A1 (en) * 1997-10-29 2003-10-30 Ajinomoto Co. Inc. Immunomodulator
SE9800932D0 (en) * 1998-03-20 1998-03-20 Astra Ab New compunds
EP1004302A3 (en) * 1998-10-29 2003-06-04 Ajinomoto Co., Inc. Immunomodulator
SE9900438D0 (en) * 1999-02-10 1999-02-10 Astra Ab The pharmacological use of certian cystine derivatives
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
NO20003591L (en) * 2000-07-13 2002-01-14 Thia Medica As Fatty acid analogues for the treatment of cancer
SE518784C2 (en) * 2000-12-27 2002-11-19 Nactilus Ab "N-Acetyl-L-Cysteine with Compositions for the Treatment of Neoplasms"
KR20040021589A (en) * 2001-03-13 2004-03-10 아지노모토 가부시키가이샤 Cosmetics or external preparations for skin
RU2317299C2 (en) * 2001-08-10 2008-02-20 Кабусики Кайся Хаясибара Сеибуцу Кагаку Associate containing trehalose and calcium chloride as crystalline monohydrate or anhydrous crystal
SI1494732T1 (en) 2002-03-20 2008-08-31 Mannking Corp Inhalation apparatus
SI1603872T1 (en) * 2003-03-11 2011-07-29 Pharmacia Corp S-?á2-?á(1-IMINOETHYL)AMINO?åETHYL?å-2-METHYL-L-CYSTEINE MALEATE HYDROCHLORIDE CRYSTALLINE SALT
KR101273120B1 (en) 2004-08-20 2013-06-13 맨카인드 코포레이션 Catalysis of diketopiperazine synthesis
BR122019022692B1 (en) 2004-08-23 2023-01-10 Mannkind Corporation THERAPEUTIC DRY POWDER COMPOSITION CONTAINING DICETOPIPERAZINE, AT LEAST ONE TYPE OF CATION AND ONE BIOLOGICALLY ACTIVE AGENT
KR101486829B1 (en) 2005-09-14 2015-01-29 맨카인드 코포레이션 Method of drug formulation based on increasing the affinity of active agents for crystalline micropaticle surfaces
EP1986679B1 (en) 2006-02-22 2017-10-25 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US8438729B2 (en) * 2006-03-09 2013-05-14 Canon Kabushiki Kaisha Method of producing liquid discharge head
TWI677355B (en) 2008-06-13 2019-11-21 美商曼凱公司 A dry powder inhaler and system for drug delivery
US8485180B2 (en) * 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
ES2421385T3 (en) * 2008-06-20 2013-09-02 Mannkind Corp Interactive device and procedure to establish the profile, in real time, of inhalation efforts
TWI614024B (en) 2008-08-11 2018-02-11 曼凱公司 Ultra-fast use of insulin
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
EP2676695A3 (en) 2009-03-11 2017-03-01 MannKind Corporation Apparatus, system and method for measuring resistance of an inhaler
MY186975A (en) 2009-06-12 2021-08-26 Mannkind Corp Diketopiperazine microparticles with defined specific surface areas
US9016147B2 (en) 2009-11-03 2015-04-28 Mannkind Corporation Apparatus and method for simulating inhalation efforts
MX359281B (en) 2010-06-21 2018-09-21 Mannkind Corp Dry powder drug delivery system and methods.
US8925726B2 (en) 2011-04-01 2015-01-06 Mannkind Corporation Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
CA2852536A1 (en) 2011-10-24 2013-05-02 Mannkind Corporation Methods and compositions for treating pain
CN102491926B (en) * 2011-12-15 2013-09-25 青岛市药品检验所 Method for preparing and purifying tiopronin disulphide
CA2878457C (en) 2012-07-12 2021-01-19 Mannkind Corporation Dry powder drug delivery systems and methods
EP2911690A1 (en) 2012-10-26 2015-09-02 MannKind Corporation Inhalable influenza vaccine compositions and methods
EP2970149B1 (en) 2013-03-15 2019-08-21 MannKind Corporation Microcrystalline diketopiperazine compositions and methods
EP3021834A1 (en) 2013-07-18 2016-05-25 MannKind Corporation Heat-stable dry powder pharmaceutical compositions and methods
CN105517607A (en) 2013-08-05 2016-04-20 曼金德公司 Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
WO2021219376A1 (en) * 2020-04-28 2021-11-04 Unilever Ip Holdings B.V. Personal care compositions with enhanced solubility actives
EP4216939A4 (en) * 2020-09-28 2024-10-23 Georgia Tech Research Corporation USE OF CYSTIN AND ITS DERIVATIVES AS ANTITHROMBOTIC AND THROMBOLYTIC AGENTS

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB592631A (en) * 1945-04-04 1947-09-24 Du Pont Cysteine and cystine
GB954268A (en) 1962-02-26 1964-04-02 Mead Johnson & Co Decongestant compositions comprising n-acylated sulphydryl compounds
FR8205M (en) * 1968-12-20 1970-09-14
US3647834A (en) * 1969-08-11 1972-03-07 Mead Johnson & Co Zinc mercaptide n-acetylcysteine carboxylate salts
US3878305A (en) * 1972-05-25 1975-04-15 Procter & Gamble Fortification of foodstuffs with n-acyl derivatives of sulphur-containing l-amino acids
US3952115A (en) * 1975-04-02 1976-04-20 The Procter & Gamble Company Fortification of foodstuffs with N-acyl derivatives of sulfur-containing L-amino acid esters
US4141734A (en) * 1975-09-11 1979-02-27 Ciba-Geiby Ag Photographic developing process
US4093739A (en) * 1977-06-15 1978-06-06 Mead Johnson & Company Mercaptoacylamidobenzoyl glycine and mucolytic process
JPS6011888B2 (en) * 1978-10-11 1985-03-28 参天製薬株式会社 Rheumatic disease treatment drug
JPS56155298A (en) 1980-05-02 1981-12-01 Tanabe Seiyaku Co Shampoo composition
FR2503151A1 (en) * 1981-04-02 1982-10-08 Morelle Jean Compsns. contg. N-butyryl alpha-aminoacid(s) - for cosmetic, hygienic, therapeutic or agricultural use
GB2097256B (en) * 1981-04-02 1985-05-30 Morelle Jean V Compositions containing n-butyryl alphaaminoacids
JPS58164566A (en) * 1982-03-09 1983-09-29 Kenji Okawa Production of cystine
US4708965A (en) 1985-09-16 1987-11-24 Morgan Lee R Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
US4724239A (en) * 1985-09-16 1988-02-09 Morgan Lee R Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine
US4827016A (en) * 1985-09-16 1989-05-02 Morgan Lee R Method and compounds for reducing dermal inflammations
JPH0660157B2 (en) * 1985-11-20 1994-08-10 三井東圧化学株式会社 Method for producing cystine from cysteine
JPS62195356A (en) * 1986-02-20 1987-08-28 Seiwa Kasei:Kk Cystine derivative and salt thereof
AT402931B (en) * 1986-11-07 1997-09-25 Pharmacia Gmbh METHOD FOR PRODUCING NEW CYSTINE COMPOUNDS AND USE THEREOF
SE8704542D0 (en) * 1987-11-19 1987-11-19 Draco Ab NEW DERIVATIVES OF CYSTEINE
IL98310A (en) * 1990-06-08 1996-08-04 Astra Ab Pharmaceutical compositions comprising cystine derivatives
TW221376B (en) * 1990-06-28 1994-03-01 Astra Ab
GB9111885D0 (en) * 1991-06-03 1991-07-24 Erba Carlo Spa Nerve growth factor for use in the prevention and treatment of viral infections

Also Published As

Publication number Publication date
HRP921322A2 (en) 1996-10-31
KR100256185B1 (en) 2000-05-15
CA2123516A1 (en) 1993-06-10
IS1645B (en) 1997-03-25
IL103778A (en) 1997-08-14
FI942504A0 (en) 1994-05-27
NO941968L (en) 1994-05-26
ES2090713T3 (en) 1996-10-16
US5650538A (en) 1997-07-22
SI9200351A (en) 1993-06-30
EP0621862B1 (en) 1996-08-28
ATE141913T1 (en) 1996-09-15
NO301325B1 (en) 1997-10-13
GR3021546T3 (en) 1997-02-28
HRP921322B1 (en) 1998-12-31
IL103778A0 (en) 1993-04-04
SK63294A3 (en) 1995-02-08
SG73962A1 (en) 2000-07-18
EP0621862A1 (en) 1994-11-02
ZA928739B (en) 1993-06-09
WO1993011104A1 (en) 1993-06-10
SE9103572D0 (en) 1991-11-29
TNSN92108A1 (en) 1993-06-08
RU2135468C1 (en) 1999-08-27
DK0621862T3 (en) 1996-09-16
IS3949A (en) 1993-05-30
HU215390B (en) 1998-12-28
US5693858A (en) 1997-12-02
AU657827B2 (en) 1995-03-23
SK281697B6 (en) 2001-06-11
CZ129794A3 (en) 1995-01-18
LV11949A (en) 1998-01-20
AU3099692A (en) 1993-06-28
CN1039586C (en) 1998-08-26
MY110523A (en) 1998-07-31
AP9200448A0 (en) 1993-01-31
DE69213256D1 (en) 1996-10-02
DE69213256T2 (en) 1997-01-23
PL170787B1 (en) 1997-01-31
US5385904A (en) 1995-01-31
EE03025B1 (en) 1997-08-15
DZ1637A1 (en) 2002-02-17
AP350A (en) 1994-08-09
JP3302018B2 (en) 2002-07-15
US5804582A (en) 1998-09-08
LV11949B (en) 1998-07-20
US5824681A (en) 1998-10-20
CZ282085B6 (en) 1997-05-14
NO941968D0 (en) 1994-05-26
JPH07501539A (en) 1995-02-16
FI942504A7 (en) 1994-05-27
MA22716A1 (en) 1993-07-01
HK62297A (en) 1997-05-16
NZ245077A (en) 1995-04-27
FI942504L (en) 1994-05-27
YU99092A (en) 1995-12-04
PL171336B1 (en) 1997-04-30
CN1073683A (en) 1993-06-30
HU9401473D0 (en) 1994-08-29
HUT70851A (en) 1995-11-28
MX9206851A (en) 1993-05-01

Similar Documents

Publication Publication Date Title
YU48594B (en) N-N'-DIACETYLCYSTINE ORGANIC SALTS AND THE PROCESS FOR THEIR PREPARATION
AR013441A1 (en) AN IMIDAZOQUINOXALINE COMPOUND, METHOD FOR THE TREATMENT OF A SUFFERING OR DISORDER ASSOCIATED WITH THE THYROSINAKINASE PROTEIN, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND METHODS FOR PREPARING SUCH COMPOUNDS AND THEIR INTERMEDIARIES
FI961809A0 (en) New (R) -5-carbamoyl-8-fluoro-3-N, N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
MX9206008A (en) PROTEOLYTIC ENZYME INHIBITORS, SACARINE 2-SUBSTITUTED DERIVATIVES.
EA200300248A1 (en) BICYCLOPIRASOLES, ACTIVE AS KINASE INHIBITORS, METHOD OF THEIR RECEIVING AND INCLUDING THEIR PHARMACEUTICAL COMPOSITIONS
YU49094B (en) Process for obtaining synenergetic therapeutic composition
HN1999000083A (en) PIRROLO COMPOUNDS (2,3-D) PYRIMIDINE
ATE114661T1 (en) BENZYLPHOSPHONIC ACID TYROSINE KINASE INHIBITORS.
UY25242A1 (en) BENZOTIAZOLE INHIBITORS OF PROTEIN THYROSINE KINASE
MX9706069A (en) Novel dipeptide amidines as thrombin inhibitors.
DK0714300T3 (en) Methods for regulating the sexual response in humans
ATE254443T1 (en) INHIBITING HAIR GROWTH
DE69115280D1 (en) INDOLDER DERIVATIVES THAT INHIBIT LEUKOTRIA BIOSYNTHESIS.
RU94019984A (en) PYRIDAZINES AS INHIBITORS OF INTERLEUKIN-1β-CONVERTING ENZYME, PHARMCOMPOSITION BASED ON THEREOF AND THEIR USE
EA200200510A1 (en) 4-CARBOXYAMINO-2-ETHYL-1,2,3,4-TETRAHYDROCHINOLINE IN A CRYSTAL FORM AS A CETR INHIBITOR
ES8802420A1 (en) A method for controlling weeds.
UA26431A (en) DERIVATIVES OF CYC-ISOMER OF CEPHALOSPORY, THEIR OPTICALLY ACTIVE APHYTOPES OR RACEMIC MIXTURE, AS WELL AS THEIR PHARMACEUTICAL ADMINISTRATIVE ACIDS
ATE35137T1 (en) THIENO(2,3-D)PYRIMIDINE DERIVATIVES AND THEIR SALTS.
ES2157899T3 (en) SAMPANGINA DERIVATIVES USEFUL AS ANTIFUNGIC AND ANTIMICOBACTERIAL AGENTS.
GB1426028A (en) 2-oxazoline derivatives
RU94014256A (en) 4-quinolinedihydropyridine, mixture of isomers thereof or individual isomers and salts thereof
YU48671B (en) NEW BETA-PHENYLISOSERINE DERIVATIVES, THEIR PRODUCTION AND USE
SE9504662D0 (en) New compounds
DE69118204D1 (en) FIGHT AGAINST PARASITIC NEMATODES
IT1216104B (en) PEPTIDES WITH PHARMACEUTICAL ACTIVITY.